Up-regulation of BMP2/4 signaling increases both osteoblast-specific marker expression and bone marrow adipogenesis in Gja1Jrt/+ stromal cell cultures

Molecular Biology of the Cell

Volumn 26, Issue 5, 2015, Pages 832-842

  Zappitelli, Tanya ^a   Chen, Frieda ^a   Aubin, Jane E ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CONNEXIN 43; CYCLIC AMP; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; BIOLOGICAL MARKER; BMP2 PROTEIN, MOUSE; BMP4 PROTEIN, MOUSE; GJA1 PROTEIN, MOUSE;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; ATROPHY; BONE MARROW STROMA CELL; BSP GENE; CELL LINEAGE; CONTROLLED STUDY; EMBRYO; GAP JUNCTION PROTEIN ALPHA1 GENE; GENE; GENE MUTATION; GENOTYPE; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; MARKER GENE; MOUSE; NONHUMAN; OCN GENE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL CULTURE; TRABECULAR BONE; UPREGULATION; ANIMAL; BONE; BONE MARROW; GENETICS; MALE; METABOLIC BONE DISEASE; METABOLISM; MUTANT MOUSE STRAIN; MUTATION; PHYSIOLOGY; STROMA CELL;

MUS;

ADIPOGENESIS; ANIMALS; BIOMARKERS; BONE AND BONES; BONE DISEASES, METABOLIC; BONE MARROW; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; CONNEXIN 43; MALE; MICE; MICE, MUTANT STRAINS; MUTATION; OSTEOBLASTS; SIGNAL TRANSDUCTION; STROMAL CELLS; UP-REGULATION;

EID: 84923812484     PISSN: 10591524     EISSN: 19394586     Source Type: Journal    
DOI: 10.1091/mbc.E14-06-1136     Document Type: Article

References (49)

1. Ai Z, Fischer A, Spray DC, Brown AM, Fishman GI (2000). Wnt-1 regulation of connexin43 in cardiac myocytes. J Clin Invest 105, 161-171.
2. Alexander DB, Goldberg GS (2003). Transfer of biologically important molecules between cells through gap junction channels. Curr Med Chem 10, 2045-2058.
3. Ashby CD, Walsh DA (1972). Characterization of the interaction of a protein inhibitor with adenosine 3′,5′-monophosphate-dependent protein kinases. I. Interaction with the catalytic subunit of the protein kinase. J Biol Chem 247, 6637-6642.
4. Ashby CD, Walsh DA (1973). Characterization of the interaction of a protein inhibitor with adenosine 3′,5′-monophosphate-dependent protein kinases. II. Mechanism of action with the holoenzyme. J Biol Chem 248, 1255-1261.
5. Azarnia R, Russell TR (1985). Cyclic AMP effects on cell-to-cell junctional membrane permeability during adipocyte differentiation of 3T3-L1 fibroblasts. J Cell Biol 100, 265-269.
6. Bivi N, Lezcano V, Romanello M, Bellido T, Plotkin LI (2011). Connexin43 interacts with betaarrestin: a pre-requisite for osteoblast survival induced by parathyroid hormone. J Cell Biochem 112, 2920-2930.
7. Bivi N, Nelson MT, Faillace ME, Li J, Miller LM, Plotkin LI (2012). Deletion of Cx43 from osteocytes results in defective bone material properties but does not decrease extrinsic strength in cortical bone. Calcif Tissue Int 91, 215-224.
8. Bivi N, Pacheco-Costa R, Brun LR, Murphy TR, Farlow NR, Robling AG, Bellido T, Plotkin LI (2013). Absence of Cx43 selectively from osteocytes enhances responsiveness to mechanical force in mice. J Orthop Res 31, 1075-1081.
9. Carson FL (1990). Histotechnology: A Self-Instructional Text, Chicago, IL: American Society for Clinical Pathology Press.
10. Chung DJ, Castro CH, Watkins M, Stains JP, Chung MY, Szejnfeld VL, Willecke K, Theis M, Civitelli R (2006). Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43. J Cell Sci 119, 4187-4198.
11. Civitelli R, Beyer EC, Warlow PM, Robertson AJ, Geist ST, Steinberg TH (1993). Connexin43 mediates direct intercellular communication in human osteoblastic cell networks. J Clin Invest 91, 1888-1896.
12. Dobrowolski R, Hertig G, Lechner H, Worsdorfer P, Wulf V, Dicke N, Eckert D, Bauer R, Schorle H, Willecke K (2009). Loss of connexin43-mediated gap junctional coupling in the mesenchyme of limb buds leads to altered expression of morphogens in mice. Hum Mol Genet 18, 2899-2911.
13. Dobrowolski R, Sasse P, Schrickel JW, Watkins M, Kim JS, Rackauskas M, Troatz C, Ghanem A, Tiemann K, Degen J, et al. (2008). The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans. Hum Mol Genet 17, 539-554.
14. Dobrowolski R, Sommershof A, Willecke K (2007). Some oculodentodigital dysplasia-associated Cx43 mutations cause increased hemichannel activity in addition to deficient gap junction channels. J Membr Biol 219, 9-17.
15. Donahue HJ, McLeod KJ, Rubin CT, Andersen J, Grine EA, Hertzberg EL, Brink PR (1995). Cell-to-cell communication in osteoblastic networks: cell line-dependent hormonal regulation of gap junction function. J Bone Miner Res 10, 881-889.
16. Dorshkind K, Green L, Godwin A, Fletcher WH (1993). Connexin-43-type gap junctions mediate communication between bone marrow stromal cells. Blood 82, 38-45.
17. Flenniken AM, Osborne LR, Anderson N, Ciliberti N, Fleming C, Gittens JE, Gong XQ, Kelsey LB, Lounsbury C, Moreno L, et al. (2005). A Gja1 missense mutation in a mouse model of oculodentodigital dysplasia. Development 132, 4375-4386.
18. Gonzalez-Nieto D, Li L, Kohler A, Ghiaur G, Ishikawa E, Sengupta A, Madhu M, Arnett J, Santho R, Dunn SK, et al. (2012). Connexin-43 in the osteogenic BM niche regulates its cellular composition and the bidirectional traffic of hematopoietic stem cells and progenitors. Blood 119, 5144-5154.
19. Grimston SK, Brodt MD, Silva MJ, Civitelli R (2008). Attenuated response to in vivo mechanical loading in mice with conditional osteoblast ablation of the connexin43 gene (Gja1). J Bone Miner Res 23, 879-886.
20. Grimston SK, Watkins MP, Brodt MD, Silva MJ, Civitelli R (2012). Enhanced periosteal and endocortical responses to axial tibial compression loading in conditional connexin43 deficient mice. PLoS One 7, e44222.
21. Jiang JX, Siller-Jackson AJ, Burra S (2007). Roles of gap junctions and hemichannels in bone cell functions and in signal transmission of mechanical stress. Front Biosci 12, 1450-1462.
22. Kim JY, Cho SW, Lee MJ, Hwang HJ, Lee JM, Lee SI, Muramatsu T, Shimono M, Jung HS (2005). Inhibition of connexin 43 alters Shh and Bmp-2 expression patterns in embryonic mouse tongue. Cell Tissue Res 320, 409-415.
23. Koval M, Geist ST, Westphale EM, Kemendy AE, Civitelli R, Beyer EC, Steinberg TH (1995). Transfected connexin45 alters gap junction permeability in cells expressing endogenous connexin43. J Cell Biol 130, 987-995.
24. Koval M, Harley JE, Hick E, Steinberg TH (1997). Connexin46 is retained as monomers in a trans-Golgi compartment of osteoblastic cells. J Cell Biol 137, 847-857.
25. Laird DW (2014). Syndromic and non-syndromic disease-linked Cx43 mutations. FEBS Lett 588, 1339-1348.
26. Lawrence TS, Beers WH, Gilula NB (1978). Transmission of hormonal stimulation by cell-to-cell communication. Nature 272, 501-506.
27. Lecanda F, Warlow PM, Sheikh S, Furlan F, Steinberg TH, Civitelli R (2000). Connexin43 deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction. J Cell Biol 151, 931-944.
28. Loewenstein WR (1981). Junctional intercellular communication: the cell-tocell membrane channel. Physiol Rev 61, 829-913.
29. Loiselle AE, Paul EM, Lewis GS, Donahue HJ (2012). Osteoblast and osteocyte-specific loss of Connexin43 results in delayed bone formation and healing during murine fracture healing. J Orthop Res 31, 147-154.
30. Malaval L, Modrowski D, Gupta AK, Aubin JE (1994). Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures. J Cell Physiol 158, 555-572.
31. McLachlan E, Plante I, Shao Q, Tong D, Kidder GM, Bernier SM, Laird DW (2008). ODDD-linked Cx43 mutants reduce endogenous Cx43 expression and function in osteoblasts and inhibit late stage differentiation. J Bone Miner Res 23, 928-938.
32. Niger C, Hebert C, Stains JP Interaction of connexin43 and protein kinase C-delta during FGF2 signaling. BMC Biochem 11, 14.
33. Paic F, Igwe JC, Nori R, Kronenberg MS, Franceschetti T, Harrington P, Kuo L, Shin DG, Rowe DW, Harris SE, Kalajzic I (2009). Identification of differentially expressed genes between osteoblasts and osteocytes. Bone 45, 682-692.
34. Plotkin LI, Lezcano V, Thostenson J, Weinstein RS, Manolagas SC, Bellido T (2008). Connexin 43 is required for the anti-apoptotic effect of bisphosphonates on osteocytes and osteoblasts in vivo. J Bone Miner Res 23, 1712-1721.
35. Plotkin LI, Manolagas SC, Bellido T (2002). Transduction of cell survival signals by connexin-43 hemichannels. J Biol Chem 277, 8648-8657.
36. Sanches DS, Pires CG, Fukumasu H, Cogliati B, Matsuzaki P, Chaible LM, Torres LN, Ferrigno CR, Dagli ML (2009). Expression of connexins in normal and neoplastic canine bone tissue. Vet Pathol 46, 846-859.
37. Scutt A, Beier N, Fittschen C (2004). EMD273316 & EMD95833, type 4 phosphodiesterase inhibitors, stimulate fibroblastic-colony formation by bone marrow cells via direct inhibition of PDE4 and the induction of endogenous prostaglandin synthesis. BMC Pharmacol 4, 10.
38. Shibayama J, Paznekas W, Seki A, Taffet S, Jabs EW, Delmar M, Musa H (2005). Functional characterization of connexin43 mutations found in patients with oculodentodigital dysplasia. Circ Res 96, e83-91.
39. Steinberg TH, Civitelli R, Geist ST, Robertson AJ, Hick E, Veenstra RD, Wang HZ, Warlow PM, Westphale EM, Laing JG, et al. (1994). Connexin43 and connexin45 form gap junctions with different molecular permeabilities in osteoblastic cells. EMBO J 13, 744-750.
40. Thomas T, Telford D, Laird DW (2004). Functional domain mapping and selective trans-dominant effects exhibited by Cx26 disease-causing mutations. J Biol Chem 279, 19157-19168.
41. Umezawa A, Hata J (1992). Expression of gap-junctional protein (connexin 43 or alpha 1 gap junction) is down-regulated at the transcriptional level during adipocyte differentiation of H-1/A marrow stromal cells. Cell Struct Funct 17, 177-184.
42. Veenstra RD, Wang HZ, Beyer EC, Brink PR (1994). Selective dye and ionic permeability of gap junction channels formed by connexin45. Circ Res 75, 483-490.
43. Watkins M, Grimston SK, Norris JY, Guillotin B, Shaw A, Beniash E, Civitelli R (2011). Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling. Mol Biol Cell 22, 1240-1251.
44. Yamada Y, Ando F, Shimokata H (2007). Association of candidate gene polymorphisms with bone mineral density in community-dwelling Japanese women and men. Int J Mol Med 19, 791-801.
45. Yanagiya T, Tanabe A, Hotta K (2007). Gap-junctional communication is required for mitotic clonal expansion during adipogenesis. Obesity (Silver Spring) 15, 572-582.
46. Yeganeh A, Stelmack GL, Fandrich RR, Halayko AJ, Kardami E, Zahradka P (2012). Connexin 43 phosphorylation and degradation are required for adipogenesis. Biochim Biophys Acta 1823, 1731-1744.
47. Zappitelli T, Chen F, Moreno L, Zirngibl RA, Grynpas M, Henderson JE, Aubin JE (2013). The G60S connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old age-related bone loss. J Bone Miner Res 28, 2400-2413.
48. Zhang Y, Paul EM, Sathyendra V, Davison A, Sharkey N, Bronson S, Srinivasan S, Gross TS, Donahue HJ (2011). Enhanced osteoclastic resorption and responsiveness to mechanical load in gap junction deficient bone. PLoS One 6, e23516.
49. Zhao S, Fernald RD (2005). Comprehensive algorithm for quantitative realtime polymerase chain reaction. J Comput Biol 12, 1047-1064.